Francis S. Willard
Eli Lilly (United States)(US)University of California, Davis(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Protein Kinase Regulation and GTPase Signaling, Diabetes Treatment and Management, Pancreatic function and diabetes, Neuropeptides and Animal Physiology
Most-Cited Works
- → G-protein signaling: back to the future(2005)478 cited
- → Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist(2020)445 cited
- → The GAPs, GEFs, and GDIs of heterotrimeric G-protein alpha subunits(2005)422 cited
- → Crystal structure of the human PRMT5:MEP50 complex(2012)359 cited
- → A Seven-Transmembrane RGS Protein That Modulates Plant Cell Proliferation(2003)328 cited
- → Translation of Polarity Cues into Asymmetric Spindle Positioning in Caenorhabditis elegans Embryos(2003)297 cited
- → LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: From discovery to clinical proof of concept